Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine butylbromide to shorten active phase of first stage of labor
TCTR20230411002Phase 0Unknown
- Sponsor
- Khon Kaen Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, double-blind trial in labor dystocia comparing Hyoscine butylbromide with Placebo (2 arms). Primary endpoint: Duration of active phase of first stage of labor. Status: unknown.
02
Drugs
hyoscine butylbromide
03
Conditions
labor dystocia
Beyond the preview
Go deeper on TCTR20230411002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230411002.